Evaluation of TypeSeq, a Novel High-Throughput, Low-Cost, Next-Generation Sequencing-Based Assay for Detection of 51 Human Papillomavirus Genotypes

BACKGROUND: Human papillomaviruses (HPV) cause over 500 000 cervical cancers each year, most of which occur in low-resource settings. Human papillomavirus genotyping is important to study natural history and vaccine efficacy. We evaluated TypeSeq, a novel, next-generation, sequencing-based assay tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagner, Sarah, Roberson, David, Boland, Joseph, Kreimer, Aimée R, Yeager, Meredith, Cullen, Michael, Mirabello, Lisa, Dunn, S Terence, Walker, Joan, Zuna, Rosemary, Porras, Carolina, Cortes, Bernal, Sampson, Joshua, Herrero, Rolando, Rodriguez, Ana Cecilia, Quint, Wim, Van Doorn, Leen-Jan, Hildesheim, Allan, Schiffman, Mark, Wentzensen, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6782103/
https://www.ncbi.nlm.nih.gov/pubmed/31536132
http://dx.doi.org/10.1093/infdis/jiz324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6782103/
https://www.ncbi.nlm.nih.gov/pubmed/31536132
http://dx.doi.org/10.1093/infdis/jiz324

Ejemplares similares